finished medicine
Scope
Date
~
-
Bio & PharmaNovel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Bio & PharmaKorea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & PharmaYbrain, Chong Kun Dang join forces for digital medicine distribution
South Korean electroceutical platform company Ybrain Inc. said on Tuesday it has entered into a joint promotion agreement with Chong Kun Dang Pharma...
Jan 31, 2023 (Gmt+09:00)
-
Bio & PharmaBridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & PharmaMedytox to build plant for finished toxin products in Dubai
South Korea's biopharmaceutical company Medytox Inc. will build a plant for finished products containing botulinum toxin in the United Arab Emirates...
Jan 17, 2023 (Gmt+09:00)
-
Bio & PharmaS.Korea's CMG Pharmaceutical opens animal medicine unit
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, on Monday announced the launch of an animal medicine unit and entry into the market f...
Dec 20, 2022 (Gmt+09:00)
-
Korean startupsAI medical startup Arpi wins Pre D.Day X SNU Medicine event
South Korean startup accelerator D.Camp hosted this year’s last demo day on Saturday in collaboration with Seoul National University’s C...
Dec 18, 2022 (Gmt+09:00)
-
EarningsCelltrion logs strong Q2 earnings powered by biosimilars
South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...
Aug 05, 2022 (Gmt+09:00)
-
Pre-IPOsLemon Healthcare aims for IPO and triple jump in revenue
Imagine making a doctor’s appointment with a click of a button on a smartphone app. Once at the clinic or hospital, the app will guide the use...
Jun 02, 2022 (Gmt+09:00)
-
Bio & PharmaKorean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
AutomobilesHyundai’s Chung named auto industry Visionary of the Year
Hyundai Motor Group Chairman Chung Euisun was named the automobile industry's Visionary of the Year by Newsweek, which credited him for driving tran...
Apr 13, 2022 (Gmt+09:00)
-
Bio & PharmaKorea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
LogisticsHyundai Glovis opens firm in Chengdu for logistics to Europe
Hyundai Glovis Co., a logistics unit of Hyundai Motor Group, has founded an affiliate in Chengdu, the largest trade city in western China, for rai...
Dec 29, 2021 (Gmt+09:00)
-
Covid-19 treatmentIndonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
